Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT06504914
- Status
- Recruiting
Conditions
- Hypertension
- Nutrition, Healthy
- Obesity
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Assigned Interventions — BEHAVIORALBehavioral: RN-CHeFRx The RN-CHeFRx trial to enhance dietary intake and blood pressure control in Black women with hypertension and obesity compared to usual care.
Study Details
Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention \- grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.
Key Dates
- Start date
- Feb 5, 2024
- Status verified
- Nov 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: ArmsParticipants will attend a 8 week intervention that includes cooking classes, grocery delivery and nutrition education.
Primary Outcome Measure
Number of participants who complete the 8 week intervention [ Time Frame: [Time Frame: Up to 8 weeks] ]
Central Contacts
- Saria Lofton312-355-2125
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Chicago | Chicago | Illinois | 60612 |
Find similar trials in Chicago, IL
By research site
Related Studies
- DNA Methylation and Vascular FunctionRecruiting · University of Illinois at Chicago · Chicago, Illinois
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Community Intervention to Reduce CardiovascuLar Disease in ChicagoRecruiting · Northwestern University · Chicago, Illinois